Cambridge Trust’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-123
Closed -$4K 912
2022
Q3
$4K Hold
123
﹤0.01% 738
2022
Q2
$4K Hold
123
﹤0.01% 775
2022
Q1
$5K Hold
123
﹤0.01% 818
2021
Q4
$6K Buy
+123
New +$6.34K ﹤0.01% 886

Other funds holding BTEC

Cambridge Trust's BTEC Position: Q4 2022 in Review

Cambridge Trust sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q4 2022, closing a stake of 123 shares — an estimated $4K sold.

Cambridge Trust first reported a position in BTEC in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q4 2021. 27 funds tracked by Wall St. Rank hold BTEC as of Q4 2022.

  • Cambridge Trust reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q4 2022 after selling out during the quarter.
  • Cambridge Trust sold 123 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q4 2022, an estimated $4K.
  • Cambridge Trust first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2021 and held it in 4 quarters.
  • Cambridge Trust's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $6K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.